- Published at
- by manilatimes.net
positive
positive
News for Pharming Group N.V. (PHGUF)
- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositivePharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions
Full-Year Revenue: Increased by 21% to $297 million.RUCONEST Revenue: Grew 11% to $252 million.Joenja Revenue: Increased by 147% to $45 million.Q4 Revenue Grow- Published at
- by seekingalpha.com
positivepositivePharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript
Pharming Group N.V. (NASDAQ:PHAR) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ETCompany ParticipantsFabrice Chouraqui - CEOStephen Toor -...- Published at
- by benzinga.com
mixedmixedG-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday - Advantage Solutions (NASDAQ:ADV), AES (NYSE:AES)
U.S. stocks were lower, with the Dow Jones index falling around 100 points on Thursday. Shares of G-III Apparel Group, Ltd. GIII gained 13.9% to $28.87 after t...- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveMorgan Stanley's Strategic Acquisition of Pharming Group Shares
Overview of the Recent Transaction Morgan Stanley, a prominent financial services firm, has recently expanded its investment portfolio by acquiring new holdings- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositivePharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amidst Challenges
Ruconest Revenue: $64 million for Q3 2023; $173 million for the first nine months of 2023.Joenja Revenue: $32 million for the first nine months of 2023.Revenue- Published at
- by manilatimes.net
mixedmixed- Published at
- by globenewswire.com
mixedmixedPharming Group reports third quarter 2024 financial results and provides business update
Third quarter 2024 total revenues increased by 12% to US$74.8 million, compared to the third quarter 2023, driven by continued strong RUCONEST® and Joenja®...